Cell sorting method
The invention provides a method of removing or reducing undifferentiated cells from a differentiated cell population contaminated or having a risk of contamination with undifferentiated cells by contacting a pigment epithelium-derived factor with the differentiated cell population to induce apoptosis of the undifferentiated cells. The invention also provides an agent for cell transplantation therapy, containing a differentiated cell population substantially free of an undifferentiated cell, which is obtained by the method, as well as an agent for inducing apoptosis of an undifferentiated cell, containing a pigment epithelium-derived factor, and combined use of the aforementioned agent for cell transplantation therapy and the aforementioned agent for inducing apoptosis.
1. A method of removing or reducing undifferentiated cells from a differentiated cell population that is contaminated or has a risk of contamination with undifferentiated cells, comprising contacting a recombinant pigment epithelium-derived factor (PEDF) with the differentiated cell population in a culture medium, and verifying that the resulting cell population is substantially free of the undifferentiated cell,
wherein the undifferentiated cell is an induced pluripotent stem (iPS) cell or an embryonic stem (ES) cell,
wherein the differentiated cell is other than a vascular endothelial cell and a corneal epithelial cell, and
wherein the method induces apoptosis of the undifferentiated cell.
2. The method according to claim 1 , wherein the undifferentiated cell is a pluripotent stem cell having differentiation potency into three germ layer lineages.
3. The method according to claim 2 , wherein the undifferentiated cell further expresses one or more undifferentiated markers selected from the group consisting of Lin28, Oct3/4 and Nanog.
4. The method according to claim 1 , wherein the differentiated cell is a cell selected from the group consisting of skin cell, eye cell, brain cell, hair cell, mouth cavity mucous membrane, lung cell, hepatocyte, stomach mucosal cell, gut cell, splenocyte, pancreatic cell, kidney cell, blood cell, peripheral blood mononuclear cell, peripheral blood lymphocyte, cord blood cell, retinal pigment epithelium, myocyte, cardiac muscle cell, chondrocyte, fibroblast, neural stem cell, hematopoietic stem cell, mesenchymal stem cell, spermatogonial stem cell, and muscle stem cell.
5. The method according to claim 1 , wherein the differentiated cell is a cell selected from the group consisting of retinal pigment epithelium, cardiac muscle cell, chondrocyte, and hepatocyte.
6. The method according to claim 1 , which does not induce apoptosis of the differentiated cell.
7. The method according to claim 1 , wherein the differentiated cell population is obtained by differentiation induction of undifferentiated cells.
8. The method according to claim 1 , wherein the verification comprises culturing the differentiated cell population under undifferentiating conditions and detecting development of an undifferentiated cell by utilizing properties specific to the undifferentiated cell.
9. The method according to claim 1 , wherein the verification comprises detecting expression of an undifferentiation specific antigen or gene.
10. A method of removing or reducing undifferentiated cells from a differentiated cell population that is contaminated or has a risk of contamination with undifferentiated cells, comprising contacting a separated conditioned medium comprising a pigment epithelium-derived factor (PEDF) with the differentiated cell population, and verifying that the resulting cell population is substantially free of the undifferentiated cell,
wherein the undifferentiated cell is an induced pluripotent stem (iPS) cell or an embryonic stem (ES) cell,
wherein the differentiated cell is other than a vascular endothelial cell and a corneal epithelial cell,
and
wherein the method induces apoptosis of the undifferentiated cell.
11. The method according to claim 10 , wherein the undifferentiated cell is a pluripotent stem cell having differentiation potency into three germ layer lineages.
12. The method according to claim 11 , wherein the undifferentiated cell further expresses one or more undifferentiated markers selected from the group consisting of Lin28, Oct3/4 and Nanog.
13. The method according to claim 10 , wherein the differentiated cell is a cell selected from the group consisting of skin cell, eye cell, brain cell, hair cell, mouth cavity mucous membrane, lung cell, hepatocyte, stomach mucosal cell, gut cell, splenocyte, pancreatic cell, kidney cell, blood cell, peripheral blood mononuclear cell, peripheral blood lymphocyte, cord blood cell, retinal pigment epithelium, myocyte, cardiac muscle cell, chondrocyte, fibroblast, neural stem cell, hematopoietic stem cell, mesenchymal stem cell, spermatogonial stem cell, and muscle stem cell.
14. The method according to claim 10 , wherein the differentiated cell is a cell selected from the group consisting of retinal pigment epithelium, cardiac muscle cell, chondrocyte, and hepatocyte.
15. The method according to claim 10 , which does not induce apoptosis of the differentiated cell.
16. The method according to claim 10 , wherein the differentiated cell population is obtained by differentiation induction of undifferentiated cells.
17. The method according to claim 10 , wherein the verification comprises culturing the differentiated cell population under undifferentiating conditions and detecting development of an undifferentiated cell by utilizing properties specific to the undifferentiated cell.
18. The method according to claim 10 , wherein the verification comprises detecting expression of an undifferentiation specific antigen or gene.